Corbus Pharmaceuticals Holdings, Inc. Increase (Decrease) in Other Noncurrent Assets
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Increase (Decrease) in Other Noncurrent Assets of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-03-09
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was $0.00.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$212.00K, a 471.93% decline from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was $57.00K.
- Corbus Pharmaceuticals Holdings, Inc. increase (decrease) in other noncurrent assets for fiscal 2018 was $3.05K, a 92.53% decline from fiscal 2017.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $0.00 derived: sum of 4 quarters · filed 2026-03-09 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $0.00 derived: sum of 3 quarters · filed 2026-03-09 | $1.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $0.00 derived: sum of 2 quarters · filed 2026-03-09 | $1.00K derived: sum of 3 quarters · filed 2026-03-09 | -$212.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.00K derived: sum of 2 quarters · filed 2025-11-12 | -$212.00K 10-Q · filed 2025-11-12 | -$201.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$212.00K 10-Q · filed 2025-08-05 | -$201.00K derived: sum of 3 quarters · filed 2025-08-05 | |
| 2024-03-31 | -$213.00K 10-Q · filed 2025-05-06 | -$202.00K derived: sum of 2 quarters · filed 2025-05-06 | ||
| 2023-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $57.00K 10-K · filed 2025-03-11 | ||
| 2023-09-30 | $46.00K 10-Q · filed 2024-11-07 | |||
| 2018-12-31 | $23.88K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$20.60K derived: sum of 2 quarters · filed 2019-03-12 | -$15.82K derived: sum of 3 quarters · filed 2019-03-12 | $3.05K 10-K · filed 2019-03-12 |
| 2018-09-30 | -$44.49K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$39.70K derived: sum of 2 quarters · filed 2018-11-08 | -$20.84K 10-Q · filed 2018-11-08 | -$45.09K derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-06-30 | $4.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $23.65K 10-Q · filed 2018-08-08 | -$599.00 derived: sum of 3 quarters · filed 2019-03-12 | -$599.00 derived: sum of 4 quarters · filed 2019-03-12 |
| 2018-03-31 | $18.86K 10-Q · filed 2018-05-10 | -$5.39K derived: sum of 2 quarters · filed 2019-03-12 | -$5.39K derived: sum of 3 quarters · filed 2019-03-12 | |
| 2017-12-31 | -$24.25K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | -$24.25K derived: sum of 2 quarters · filed 2019-03-12 | $40.78K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $65.03K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $65.03K 10-Q · filed 2018-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |